Status:
ACTIVE_NOT_RECRUITING
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Cervical Carcinoma
Endometrial Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
The study investigates whether certain characteristics of gynecological cancer can help researchers predict how well a patient recovers from surgery to remove the lower colon, rectum, and bladder, and...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the types of complications experienced by women who undergo pelvic exenteration at University of Texas (UT) MD Anderson Cancer Center. II. To determine whether th...
Eligibility Criteria
Inclusion
- Women with a history of gynecologic malignancy, including cervical, endometrial, vulvar, or vaginal carcinoma of any histology
- Women who have undergone a pelvic exenteration after January 1993 or who are being offered a pelvic exenteration for treatment of their gynecologic malignancy
- Patients must be suitable candidates for surgery (in case of prospective collection)
- Patients who have signed an approved informed consent
- Patients with a prior malignancy allowed if \> 3 years previous with no current evidence of disease
- Women must be able to read and write in either Spanish or English
Exclusion
- Patients with contraindications to surgery
- Patients unwilling or unable to complete self-administered questionnaires
- Patients who do not read or speak English or Spanish
Key Trial Info
Start Date :
July 11 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2027
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT00791635
Start Date
July 11 2008
End Date
September 30 2027
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030